Literature DB >> 10380877

Mutant p53 proteins stimulate spontaneous and radiation-induced intrachromosomal homologous recombination independently of the alteration of the transactivation activity and of the G1 checkpoint.

Y Saintigny1, D Rouillard, B Chaput, T Soussi, B S Lopez.   

Abstract

We report here a systematic analysis of the effects of different p53 mutations on both spontaneous and radiation-stimulated homologous recombination in mouse L cells. In order to monitor different recombination pathways, we used both direct and inverted repeat recombination substrates. In each line bearing one of these substrates, we expressed p53 proteins mutated at positions: 175, 248 or 273. p53 mutations leading to an increased spontaneous recombination rate also stimulate radiation-induced recombination. The effect on recombination may be partially related to the conformation of the p53 protein. Moreover, p53 mutations act on recombination between direct repeats as well as between inverted repeats indicating that strand invasion mechanisms are stimulated. Although all of the p53 mutations affect the p53 transactivation activity measured on the WAF1 and MDM2 gene promoters, no correlation between the transactivation activity and the extent of homologous recombination can be drawn. Finally, some p53 mutations do not affect the G1 arrest after radiation but stimulate radiation-induced recombination. These results show that the role of p53 on transactivation and G1 cell cycle checkpoint is separable from its involvement in homologous recombination. A direct participation of p53 in the recombination mechanism itself is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10380877     DOI: 10.1038/sj.onc.1202941

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  Characterization of mammalian RAD51 double strand break repair using non-lethal dominant-negative forms.

Authors:  S Lambert; B S Lopez
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

Review 2.  Manipulating the mammalian genome by homologous recombination.

Authors:  K M Vasquez; K Marburger; Z Intody; J H Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

3.  A novel role for the Bcl-2 protein family: specific suppression of the RAD51 recombination pathway.

Authors:  Y Saintigny; A Dumay; S Lambert; B S Lopez
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

4.  An xrcc4 defect or Wortmannin stimulates homologous recombination specifically induced by double-strand breaks in mammalian cells.

Authors:  Fabien Delacôte; Mingguang Han; Thomas D Stamato; Maria Jasin; Bernard S Lopez
Journal:  Nucleic Acids Res       Date:  2002-08-01       Impact factor: 16.971

5.  p53 differentially inhibits cell growth depending on the mechanism of telomere maintenance.

Authors:  Zaineb R Abdul Razak; Robert J Varkonyi; Michelle Kulp-McEliece; Corrado Caslini; Joseph R Testa; Maureen E Murphy; Dominique Broccoli
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

6.  Discriminatory suppression of homologous recombination by p53.

Authors:  Sheng Yun; Chadwick Lie-A-Cheong; Andrew C G Porter
Journal:  Nucleic Acids Res       Date:  2004-12-15       Impact factor: 16.971

7.  p53 mediates senescence-like arrest induced by chronic replicational stress.

Authors:  Andriy Marusyk; Linda J Wheeler; Christopher K Mathews; James DeGregori
Journal:  Mol Cell Biol       Date:  2007-05-21       Impact factor: 4.272

8.  DNA substrate dependence of p53-mediated regulation of double-strand break repair.

Authors:  Nuray Akyüz; Gisa S Boehden; Silke Süsse; Andreas Rimek; Ute Preuss; Karl-Heinz Scheidtmann; Lisa Wiesmüller
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

Review 9.  Revisiting p53 for cancer-specific chemo- and radiotherapy: ten years after.

Authors:  Jason M Beckta; Syed Farhan Ahmad; Hu Yang; Kristoffer Valerie
Journal:  Cell Cycle       Date:  2014-02-07       Impact factor: 4.534

10.  DNA damage response to the Mdm2 inhibitor nutlin-3.

Authors:  Rajeev Verma; Marc J Rigatti; Glenn S Belinsky; Cassandra A Godman; Charles Giardina
Journal:  Biochem Pharmacol       Date:  2010-02-15       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.